hexafluoroisopropanol has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliezer, D; Sung, YH | 1 |
| Kessler, JC; Lansbury, PT; Rochet, JC | 1 |
2 other study(ies) available for hexafluoroisopropanol and Parkinson Disease
| Article | Year |
|---|---|
Structure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region.
Topics: Alcohols; alpha-Synuclein; Humans; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Propanols; Protein Aggregates; Protein Structure, Secondary; Trifluoroethanol | 2018 |
The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.
Topics: alpha-Synuclein; Amino Acid Sequence; Amyloid; Circular Dichroism; Cloning, Molecular; Humans; Molecular Sequence Data; Nerve Tissue Proteins; Parkinson Disease; Peptide Fragments; Propanols; Protein Folding; Protein Isoforms; Protein Structure, Secondary; Protein Structure, Tertiary; Repetitive Sequences, Amino Acid; Synucleins | 2003 |